GoodRx Holdings, Inc. GDRX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 91.8%-2.0pp | 92.8%-1.1pp | 93.5%-0.1pp | 93.7%+1.2pp | 93.8%+2.0pp | |
| Operating margin | 9.9%-0.3pp | 11%+2.7pp | 10.4%+6.6pp | 11.1%+14.9pp | 10.3%+14.3pp | |
| Net margin | 2.6%-1.0pp | 3.8%+1.8pp | 4%+6.0pp | 4.3%+11.9pp | 3.6%+4.4pp | |
| EBITDA margin | 20.8%+1.2pp | 21.7%+4.6pp | 20.5%+4.9pp | 20.8%+10.4pp | 19.6%+9.4pp | |
| Free cash flow margin | 21%+2.3pp | 20.6%-2.4pp | 22.1%+2.7pp | 23.7%+7.3pp | 18.8%-0.5pp | |
| Returns | ||||||
| Return on equity | 3.2%-1.2pp | 4.5%+2.3pp | 4.9%+7.0pp | 5.3%+12.8pp | 4.4%+5.3pp | |
| Return on assets | 1.2%-0.8pp | 2.2%+1.1pp | 2.4%+3.4pp | 2.5%+6.2pp | 2.1%+2.5pp | |
| Return on invested capital | 4.3%-1.4pp | 5.5%+1.3pp | 5.8%+2.2pp | 6.3%+9.7pp | 5.7%+9.6pp | |
| Efficiency | ||||||
| Asset turnover | 0.5×-0.1× | 0.6×0.0× | 0.6×+0.1× | 0.6×+0.1× | 0.6×+0.1× | |
| Liquidity | ||||||
| Current ratio | 1.5×-3.8× | 2.6×-2.7× | 3.1×-2.4× | 4.2×-3.1× | 5.2×-1.1× | |
| Quick ratio | 1.5×-3.8× | 2.6×-2.7× | 3.1×-2.4× | 4.2×-3.1× | 5.2×-1.1× | |
| Cash ratio | 0.3×-2.6× | 1.1×-2.6× | 1.5×-2.2× | 2.1×-3.0× | 2.9×-1.7× | |
| Leverage | ||||||
| Debt-to-equity | 0.9×0.0× | 0.9×+0.1× | 0.9×+0.1× | 0.9×-0.2× | 0.8×-0.3× | |
| Debt-to-assets | 0.3×-0.2× | 0.4×0.0× | 0.4×0.0× | 0.4×-0.1× | 0.4×-0.1× | |
| Net debt / EBITDA | 1.9×+0.3× | 1.6×+0.9× | 1.7×+0.7× | 1.6×-0.7× | 1.5×-0.7× | |
| Interest coverage | 1.9×+0.2× | 2.1×+0.8× | 1.9×+1.4× | 2×+2.5× | 1.7×+2.2× | |
| Per Share | ||||||
| Book value per share | $1.82+5.7% | $1.73-6.6% | $1.73-3.7% | $1.80+3.5% | $1.72+6.5% | |
| Valuation | ||||||
| Market capitalization | $934.74M-44.5% | $919.86M-48.1% | $1.47B-43.7% | $1.81B-40.5% | $1.69B-40.9% | |
| Enterprise value | $1.24B-35.4% | $1.2B-35.7% | $1.74B-36.3% | $2.08B-35.6% | $1.93B-36.4% | |
| Price / earnings | 45.5×-13.8× | 30.2×— | 46.3×— | —— | —— | |
| Price / sales | 1.2×-0.9× | 1.2×-1.1× | 1.8×-1.5× | 2.3×-1.7× | 2.1×-1.6× | |
| Price / book | 1.5×-1.0× | 1.5×-1.0× | 2.4×-1.3× | 2.8×-1.7× | 2.6×-2.0× | |
| EV / EBITDA | 7.4×-4.6× | 7×-6.8× | 10.6×-11.5× | 12.5×-27.7× | 12.4×-26.7× | |
| EV / sales | 1.5×-0.8× | 1.5×-0.8× | 2.2×-1.3× | 2.6×-1.6× | 2.4×-1.6× | |
| Free cash flow yield | 18.2%+9.1pp | 17.9%+7.6pp | 12.1%+6.2pp | 10.5%+6.3pp | 8.9%+3.7pp | |
| Earnings yield | 2.3%+0.5pp | 3.3%+2.4pp | 2.2%+2.8pp | 1.9%+3.8pp | 1.7%+1.9pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are GoodRx Holdings, Inc.'s profit margins?
- GoodRx Holdings, Inc. (GDRX) runs a 91.8% gross margin and a 9.9% operating margin, with a 2.6% net margin.
- Where do GoodRx Holdings, Inc.'s ratios come from?
- Every ratio is computed from GoodRx Holdings, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
